Cellular apoptosis · target hub
TP53 (TP53)
TP53 is a BCL-2 family on the Apoptosis signaling pathway axis. Validate with UniProt and literature. Indexed under "p53 & DNA-damage axis" for antibodies and assay guidance.
| Type / example | Domain / context (brief) |
|---|---|
| Loss-of-function | Loss/truncation |
| CN loss | Copy loss |
| Rare missense | Require functional validation |
Naming and prevalence vary—annotate clinically with authoritative databases.
Examples below reflect common literature and public resources (e.g., CCLE, DepMap)—validate genotypes, expression, and passage in your own stocks before committing assays.
Human tissues and primary cells require ethics/IRB approval; tumors are heterogeneous—record histotype, site, and preservation conditions.
Overexpression vs endogenous TP53 can differ in dosage, splicing, and compartmentation.
Adds TP53 keyword bias atop the 凋亡信号通路 antibody pool—if sparse, use presets above or global search.
This content supports research reagents and pathway education—not medical advice. Annotate mutations, drug indications, and protocols with authoritative databases, datasheets, and institutional oversight.
Last reviewed: 2026-05-18
See the cellular apoptosis hub for neighboring targets—cross-check PI3K, MAPK, and transmembrane transport pages as needed.